GBL Hisoar Ltd

Category: Health & Medicines > Medicines > Ivabradine

Country/Region: China State/Province: Shandong

Main Products: Ivabradine, Eplerenone, Nitrazepam, Medetomidine, Atipamezole, Naproxcinod, Prasugrel, Tolvaptan

Company Introduction

GBL Hisoar Limited is a professional enterprise engaged in researching, developing, synthesizing, and manufacturing pharmaceutical intermediates and fine chemicals.

Company Overview

Business Type: Exporter, Buying House

Year Established: 2000

Employees: 51 - 100 People

Plant Area: Below 1,000 square meters

Contact Information

Fax: 86-531-86940465

Business Information

Main Markets: South America 11% Africa 12% Eastern Asia 10% Domestic Market 10% North America 8% Eastern Europe 11% Southern Europe 9% Mid East 8% Northern Europe 10% Oceania 11%

Trade Capacity: FOB, FCA, DES

Contract Manufacturing: OEM Service Offered,Buyer Label Offered

Nearest Port: Jinan

Trade & Financial Information

Annual Revenue: US$50 Million - US$100 Million

Total Revenue: US$50 Million - US$100 Million

Export Revenue: confidential

Annual Output: confidential

Registered Capital: US$50 Million - US$100 Million

Export Percentage: 71% - 80%

Payment Modes: USD, CAD, CHF

Lead Time: 34 days

Import/Export Mode: Have Own Export License

Product Showcase

•Ivabradine

•Eplerenone

•Nitrazepam

•Medetomidine

•Atipamezole

•Naproxcinod

•Prasugrel

•Tolvaptan

CL-Link > Health & Medicines in China Health & Medicines in Shandong Medicines in China Medicines in Shandong Ivabradine in China Ivabradine in Shandong